Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation.
暂无分享,去创建一个
[1] V. Bamm,et al. Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. , 2003, Biochemistry.
[2] M. Fishbein,et al. Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL , 2001, Circulation.
[3] D. Lange,et al. Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis. , 1989, Journal of periodontal research.
[4] E. Smart,et al. Lipids: potential regulators of nitric oxide generation. , 2004, American journal of physiology. Endocrinology and metabolism.
[5] M. Nakano,et al. Formation of ceramide‐enriched domains in lipid particles enhances the binding of apolipoprotein E , 2005, FEBS letters.
[6] W. Nacken,et al. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. , 2001, Biochemistry.
[7] T. Michel,et al. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. , 1998, Biochemistry.
[8] D. Srivastava,et al. Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.
[9] M. Krieger,et al. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). , 1994, Annual review of biochemistry.
[10] M. Quon,et al. High Density Lipoprotein-induced Endothelial Nitric-oxide Synthase Activation Is Mediated by Akt and MAP Kinases* , 2003, The Journal of Biological Chemistry.
[11] T. Kelley,et al. Macrophage-Colony-Stimulating Factor-Induced Activation of Extracellular-Regulated Kinase Involves Phosphatidylinositol 3-Kinase and Reactive Oxygen Species in Human Monocytes1 , 2002, The Journal of Immunology.
[12] Pin-Lan Li,et al. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. , 2004, Kidney international.
[13] R. Evans,et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.
[14] J. Heinecke,et al. Oxidized HDL: the paradox-idation of lipoproteins. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[15] J. Eaton,et al. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] T. Sawamura,et al. Oxidized Low Density Lipoprotein (ox-LDL) Binding to ox-LDL Receptor-1 in Endothelial Cells Induces the Activation of NF-κB through an Increased Production of Intracellular Reactive Oxygen Species* , 2000, The Journal of Biological Chemistry.
[17] S. Yokoyama,et al. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.
[18] E. Vizi,et al. Shaping of monocyte and macrophage function by adenosine receptors. , 2007, Pharmacology & therapeutics.
[19] B. Brüne,et al. Oxidized low-density lipoprotein depletes PKCalpha and attenuates reactive oxygen species formation in monocytes/macrophages. , 2006, Cardiovascular research.
[20] M. Nakano,et al. Ceramide in Lipid Particles Enhances Heparan Sulfate Proteoglycan and Low Density Lipoprotein Receptor-related Protein-mediated Uptake by Macrophages* , 2004, Journal of Biological Chemistry.
[21] M. Nikolova-Karakashian,et al. High Density Lipoprotein Binding to Scavenger Receptor, Class B, Type I Activates Endothelial Nitric-oxide Synthase in a Ceramide-dependent Manner* , 2002, The Journal of Biological Chemistry.
[22] G. Assmann,et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. , 2004, The Journal of clinical investigation.
[23] M. Cybulsky,et al. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.
[24] M. Raftery,et al. Oxidation of High Density Lipoproteins , 1998, The Journal of Biological Chemistry.
[25] Gerd Schmitz,et al. ABCA1: regulation, trafficking and association with heteromeric proteins , 2002, Annals of medicine.
[26] V. Pasceri,et al. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. , 2000, Circulation.
[27] T. Ganz. Hepcidin--a peptide hormone at the interface of innate immunity and iron metabolism. , 2006, Current topics in microbiology and immunology.
[28] M. Kinter,et al. Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells* , 2006, Journal of Biological Chemistry.
[29] Barry Halliwell,et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils , 1998, Nature.
[30] M. Aviram,et al. Flavonoids protect LDL from oxidation and attenuate atherosclerosis , 2001, Current opinion in lipidology.
[31] T. Willson,et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase , 1999, Nature.
[32] A. Ramachandran,et al. Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. , 2005, American journal of physiology. Heart and circulatory physiology.
[33] R. Kolesnick,et al. Raft ceramide in molecular medicine , 2003, Oncogene.
[34] R. Silverstein,et al. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.
[35] Masashi Komeda,et al. Expression of SR-PSOX, a Novel Cell-Surface Scavenger Receptor for Phosphatidylserine and Oxidized LDL in Human Atherosclerotic Lesions , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[36] S. Legrand-Poels,et al. Perturbation of actin dynamics induces NF-kappaB activation in myelomonocytic cells through an NADPH oxidase-dependent pathway. , 2005, The Biochemical journal.
[37] H. Harizi,et al. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. , 2006, Cellular & molecular immunology.
[38] Kohei Miyazono,et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.
[39] N. Weeratunge,et al. Toxicity of oxysterols to human monocyte-macrophages. , 1995, Atherosclerosis.
[40] Y. Yoo,et al. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. , 1998, Biochemistry.
[41] D. Steinberg,et al. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. , 2001, Journal of lipid research.
[42] N. Brot,et al. Myeloperoxidase Impairs ABCA1-dependent Cholesterol Efflux through Methionine Oxidation and Site-specific Tyrosine Chlorination of Apolipoprotein A-I* , 2006, Journal of Biological Chemistry.
[43] T. Langmann,et al. The Scavenger Receptor CD163: Regulation, Promoter Structure and Genomic Organization , 2000, Pathobiology.
[44] C. Glass,et al. Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein , 1998 .
[45] M. Nakano,et al. Effects of sphingomyelin on apolipoprotein E- and lipoprotein lipase-mediated cell uptake of lipid particles. , 2003, Biochimica et biophysica acta.
[46] Reto Asmis,et al. Molecular mechanism of glutathione-mediated protection from oxidized low-density lipoprotein-induced cell injury in human macrophages: role of glutathione reductase and glutaredoxin. , 2006, Free radical biology & medicine.
[47] A. Shah,et al. Peroxisome Proliferator–Activated Receptor &agr; Induces NADPH Oxidase Activity in Macrophages, Leading to the Generation of LDL with PPAR-&agr; Activation Properties , 2004 .
[48] E. Gulbins,et al. Ceramide-enriched membrane domains. , 2005, Biochimica et biophysica acta.
[49] J. Lehmann,et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.
[50] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[51] H. Hydén,et al. A receptor for phosphatidylserine-speci ® c clearance of apoptotic cells , 2000 .
[52] L. Papadopoulou,et al. Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. , 2006, Pharmacology & therapeutics.
[53] K. Williams,et al. The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[54] M. Cathcart,et al. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[55] R. Kolesnick,et al. Does endotoxin stimulate cells by mimicking ceramide? , 1995, Immunology today.
[56] S. Bhakdi,et al. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions , 1990, The Journal of experimental medicine.
[57] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[58] L. Szweda,et al. Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal. , 1998, Biochemistry.
[59] F. DeLeo,et al. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins , 1996, Journal of leukocyte biology.
[60] S. Goerdt,et al. Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+++, MS-1± 25F9−) in psoriatic dermis , 1996, Archives of Dermatological Research.
[61] E. Gulbins,et al. Lipid Raft Clustering and Redox Signaling Platform Formation in Coronary Arterial Endothelial Cells , 2006, Hypertension.
[62] R. Kolesnick,et al. Ceramide and sphingosine 1-phosphate in anti-cancer therapies. , 2003, Cancer treatment and research.
[63] A. Landar,et al. Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. , 2005, Biochemical Society transactions.
[64] D. Shih,et al. The role of high-density lipoproteins in oxidation and inflammation. , 2001, Trends in cardiovascular medicine.
[65] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[66] G. Schmitz,et al. Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. , 2001, Atherosclerosis.
[67] Chandan K Sen,et al. The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survival. , 2007, American journal of respiratory cell and molecular biology.
[68] G. Zimmerman,et al. Plasma Platelet-activating Factor Acetylhydrolase Is a Secreted Phospholipase A2 with a Catalytic Triad (*) , 1995, The Journal of Biological Chemistry.
[69] Jeffrey B. Kopp,et al. TGF- and fibrosis , 1999 .
[70] G. Schütz,et al. Lipopolysaccharide and ceramide docking to CD14 provokes ligand‐specific receptor clustering in rafts , 2001, European journal of immunology.
[71] M. Takeya,et al. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals , 2002, Medical Electron Microscopy.
[72] Xi-Ping Huang,et al. Mitochondrial involvement in genetically determined transition metal toxicity I. Iron toxicity. , 2006, Chemico-biological interactions.
[73] G. Francis,et al. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[74] V. Darley-Usmar,et al. Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages. , 1993, The Biochemical journal.
[75] A. Sevanian,et al. OxLDL induces macrophage gamma-GCS-HS protein expression: a role for oxLDL-associated lipid hydroperoxide in GSH synthesis. , 2001, Journal of lipid research.
[76] M. Jaye,et al. Thioredoxin reductase 1 is upregulated in atherosclerotic plaques: specific induction of the promoter in human macrophages by oxidized low-density lipoproteins. , 2004, Free radical biology & medicine.
[77] E. Murphy,et al. S-nitrosylation: NO-related redox signaling to protect against oxidative stress. , 2006, Antioxidants & redox signaling.
[78] J. Heuser,et al. Endocytosis of Oxidized Low Density Lipoprotein through Scavenger Receptor CD36 Utilizes a Lipid Raft Pathway That Does Not Require Caveolin-1* , 2003, Journal of Biological Chemistry.
[79] K. Hirata,et al. Expression of Glutaredoxin in Human Coronary Arteries: Its Potential Role in Antioxidant Protection Against Atherosclerosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[80] E. Stanley,et al. Colony-stimulating factor-1 in immunity and inflammation. , 2006, Current opinion in immunology.
[81] G. Poli,et al. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. , 2005, Molecular nutrition & food research.
[82] K. Gaus,et al. Oxidized lipoproteins and macrophages. , 2002, Vascular pharmacology.
[83] T. Langmann,et al. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.
[84] W. Nacken,et al. S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity , 2003, Microscopy research and technique.
[85] G. Schütz,et al. Apo AI/ABCA1‐Dependent and HDL3‐Mediated Lipid Efflux from Compositionally Distinct Cholesterol‐Based Microdomains , 2002, Traffic.
[86] L. Nagy,et al. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease. , 1999, Current opinion in lipidology.
[87] Gaochao Zhou,et al. 27-Hydroxycholesterol Is an Endogenous Ligand for Liver X Receptor in Cholesterol-loaded Cells* , 2001, The Journal of Biological Chemistry.
[88] Helen H. Hobbs,et al. Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.
[89] M. Wilson,et al. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. , 1996, Journal of lipid research.
[90] J. Huang,et al. TGF‐β control of cell proliferation , 2005 .
[91] S. Gordon,et al. A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. , 1998, Journal of lipid research.
[92] T. K. van den Berg,et al. The macrophage scavenger receptor CD163. , 2005, Immunobiology.
[93] D. Simon,et al. Integrin signals, transcription factors, and monocyte differentiation. , 2006, Trends in cardiovascular medicine.
[94] R. Dean,et al. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. , 1993, Analytical biochemistry.
[95] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[96] G. Poli,et al. Oxidized products of cholesterol: dietary and metabolic origin, and proatherosclerotic effects (review). , 2002, The Journal of nutritional biochemistry.
[97] P. Libby,et al. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. , 1998, Circulation research.
[98] J. Mehta,et al. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. , 2000, Circulation.
[99] R. Evans,et al. Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.
[100] V. O’Donnell,et al. Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease , 2001, Circulation research.
[101] D. Steinberg,et al. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[102] A. Tedgui,et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. , 2000, Circulation.
[103] H. Masutani,et al. Redox regulation by thioredoxin in cardiovascular diseases. , 2003, Antioxidants & redox signaling.
[104] R. Kinscherf,et al. Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis , 2001 .
[105] Xavier Collet,et al. Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis , 2003, Nature.
[106] P. Edwards,et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[107] D. Hume,et al. Endotoxin signal transduction in macrophages , 1996, Journal of leukocyte biology.
[108] B. Beutler,et al. Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.
[109] Elias S. J. Arnér,et al. Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.
[110] T. Kodama,et al. Collagenous macrophage scavenger receptors , 1996, Current opinion in lipidology.
[111] S. Daniels,et al. Serum glutathione in adolescent males predicts parental coronary heart disease. , 1999, Circulation.
[112] E. Ikonen,et al. Functional rafts in cell membranes , 1997, Nature.
[113] A. Daugherty,et al. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.
[114] L. Rajendran,et al. Lipid rafts and membrane dynamics , 2005, Journal of Cell Science.
[115] D. Tew,et al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. , 1999, The Biochemical journal.
[116] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[117] A. Nègre-Salvayre,et al. Oxidized low-density lipoprotein-induced apoptosis. , 2002, Biochimica et biophysica acta.
[118] S. Bhakdi,et al. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety , 1995, The Journal of experimental medicine.
[119] H. Ochi,et al. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[120] S. Teitelbaum,et al. αvβ3 and macrophage colony‐stimulating factor: partners in osteoclast biology , 2005 .
[121] M. Yacoub,et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[122] P. Libby,et al. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. , 2001, The American journal of pathology.
[123] K. Jakobs,et al. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. , 2007, Biochimica et biophysica acta.
[124] K. Mori,et al. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[125] P. Libby,et al. Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro , 1998 .
[126] R. Stocker,et al. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[127] Elias S. J. Arnér,et al. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.
[128] E. Leibold,et al. Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species. , 1999, Gene expression.
[129] P. Reaven,et al. Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[130] Yoshimasa Nakamura,et al. Activation of Stress Signaling Pathways by the End Product of Lipid Peroxidation , 1999, The Journal of Biological Chemistry.
[131] T. Kondo,et al. Diversity and complexity of ceramide signalling in apoptosis. , 1998, Cellular signalling.
[132] S. Parthasarathy,et al. Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[133] Michael Aviram,et al. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants , 1998, Molecular and Cellular Biochemistry.
[134] S. Goerdt,et al. Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. , 1993, The American journal of pathology.
[135] A. Nègre-Salvayre,et al. Dual Role of Oxidized LDL on the NF-KappaB Signaling Pathway , 2004, Free radical research.
[136] B. van Deurs,et al. The phagocyte NADPH oxidase depends on cholesterol‐enriched membrane microdomains for assembly , 2004, The EMBO journal.
[137] I. Yuhanna,et al. Oxidized Low Density Lipoprotein Displaces Endothelial Nitric-oxide Synthase (eNOS) from Plasmalemmal Caveolae and Impairs eNOS Activation* , 1999, The Journal of Biological Chemistry.
[138] P. Barter,et al. Antiinflammatory Properties of HDL , 2004 .
[139] E. Gulbins,et al. Ceramide and cell death receptor clustering. , 2002, Biochimica et biophysica acta.
[140] S. Altamentova,et al. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin. , 1997, Biochemistry.
[141] K. Kwiatkowska,et al. Cell Surface Ceramide Generation Precedes and Controls FcγRII Clustering and Phosphorylation in Rafts* , 2004, Journal of Biological Chemistry.
[142] G. Struhl,et al. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb , 1998, Nature.
[143] R. Stocker,et al. Oxidation of High Density Lipoproteins , 1998, The Journal of Biological Chemistry.
[144] Jianglin Fan,et al. Inflammatory reactions in the pathogenesis of atherosclerosis. , 2003, Journal of atherosclerosis and thrombosis.
[145] T. Kita,et al. An endothelial receptor for oxidized low-density lipoprotein , 1997, Nature.
[146] R. Stocker. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance , 1994, Current opinion in lipidology.
[147] D. Steinberg,et al. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[148] S. Rankin,et al. Modification of low-density lipoproteins by flavonoids. , 1990, Biochemical Society transactions.
[149] P. Mladěnka,et al. The role of reactive oxygen and nitrogen species in cellular iron metabolism , 2006, Free radical research.
[150] D. Steinberg,et al. Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.
[151] P. Svensson,et al. Oxidized LDL induces a coordinated up-regulation of the glutathione and thioredoxin systems in human macrophages. , 2006, Atherosclerosis.
[152] B. Brüne,et al. Dualism of Oxidized Lipoproteins in Provoking and Attenuating the Oxidative Burst in Macrophages: Role of Peroxisome Proliferator-Activated Receptor-γ1 , 2002, The Journal of Immunology.
[153] F. Byfield,et al. OxLDL increases endothelial stiffness, force generation, and network formations⃞s⃞ The online version of this article (available at http://www.jlr.org) contains two additional figures. Published, JLR Papers in Press, January 17, 2006. , 2006, Journal of Lipid Research.
[154] F. Pixley,et al. CSF-1 regulation of the wandering macrophage: complexity in action. , 2004, Trends in cell biology.
[155] G. Francis,et al. Administration of Tyrosyl Radical–Oxidized HDL Inhibits the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[156] V. Darley-Usmar,et al. Treatment of macrophages with oxidized low-density lipoprotein increases their intracellular glutathione content. , 1991, The Biochemical journal.
[157] D. Steinberg,et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.